Compound information
- Natural Products
- NACP3434
- Molecular Formula
- C23H34N6O6
- Molecular Weight
- 490.253982808 g/mol
- Structure
-
- IUPAC Name
- 2-[[1-[2-(benzyloxycarbonylamino)propanoyl]piperidine-4-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C23H34N6O6/c1-15(27-23(34)35-14-16-6-3-2-4-7-16)20(31)29-12-9-17(10-13-29)19(30)28-18(21(32)33)8-5-11-26-22(24)25/h2-4,6-7,15,17-18H,5,8-14H2,1H3,(H,27,34)(H,28,30)(H,32,33)(H4,24,25,26)
- InChI Key
- AMJCPPMNFSIXHV-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)N2CCC(C(=O)NC(C(=O)O)CCCNC(=N)N)CC2)C
- CAS
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0362500
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 35 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 11 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 186.94 Å2 | LogP | -1.075 |
LogS | -2.649 | LogD | -0.182 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.001 | Pgp substrate | 0.998 |
HIA | 0.0 | F20 % | 0.256 |
F30 % | 0.0 | Caco-2 | -6.929 |
MDCK | -6.025 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.157 | PPB | 46.92 |
VD | 0.163 | Fu | 0.322 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.389 |
CYP2A6 substrate | 0.18 | CYP2B6 substrate | 0.414 |
CYP2C19 inhibitor | 0.04 | CYP2C19 substrate | 0.336 |
CYP2C8 substrate | 0.425 | CYP2C9 inhibitor | 0.166 |
CYP2C9 substrate | 0.033 | CYP2D6 inhibitor | 0.048 |
CYP2D6 substrate | 0.216 | CYP2E1 substrate | 0.242 |
CYP3A4 inhibitor | 0.016 | CYP3A4 substrate | 0.06 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.642 | CL | 2.331 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.146 | Hepatotoxicity | 0.157 |
Mutagenicity | 0.046 | Rat Oral Acute Toxicity | 0.033 |
FDAMDD | 0.133 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.078 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.205 | IGC50 | 1.921 |
LC50FM | -4.157 | LC50DM | -1.175 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.408 | NR-AR-LBD | 0.305 |
NR-AhR | 0.003 | NR-Aromatase | 0.021 |
NR-ER | 0.303 | NR-ER-LBD | 0.348 |
NR-PPAR-gamma | 0.341 | SR-ARE | 0.15 |
SR-ATAD5 | 0.321 | SR-HSE | 0.129 |
SR-MMP | 0.007 | SR-p53 | 0.038 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.